Literature DB >> 12693641

A longitudinal study of attitudes toward physician-assisted suicide and euthanasia among patients with noncurable malignancy.

Jaime Pacheco1, Paul J Hershberger, Ronald J Markert, Geetika Kumar.   

Abstract

This longitudinal study investigated whether attitudes toward physician-assisted suicide (PAS) and euthanasia (E) are stable among patients with noncurable malignancy, and whether depression and various coping strategies were related to such attitudes. Thirty patients with noncurable malignancies completed questionnaires measuring attitudes toward PAS and E, depression, and coping. Three months later, and subsequently at six-month intervals, repeated measures were obtained from 24 patients. There was a trend for patients to become less supportive of legalizing PAS and E from the initial to last attitude measurement. Depression was unrelated to attitude change. There were significant changes on two coping dimensions: use of social support for emotional reasons and use of religious resources. Our findings should be considered in clinical, legislative, and ethical debates.

Entities:  

Keywords:  Death and Euthanasia; Empirical Approach

Mesh:

Year:  2003        PMID: 12693641     DOI: 10.1177/104990910302000207

Source DB:  PubMed          Journal:  Am J Hosp Palliat Care        ISSN: 1049-9091            Impact factor:   2.500


  2 in total

1.  Attitude towards Euthanasia among Medical Students: A Cross-Sectional Study in Hong Kong.

Authors:  Amy Mei-Yin Lau; Eliza Lai-Yi Wong
Journal:  Int J Environ Res Public Health       Date:  2022-06-23       Impact factor: 4.614

2.  Medical Assistance in Dying in patients with advanced cancer and their caregivers: a mixed methods longitudinal study protocol.

Authors:  Madeline Li; Gilla K Shapiro; Roberta Klein; Anne Barbeau; Anne Rydall; Jennifer A H Bell; Rinat Nissim; Sarah Hales; Camilla Zimmermann; Rebecca K S Wong; Gary Rodin
Journal:  BMC Palliat Care       Date:  2021-07-21       Impact factor: 3.234

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.